Comment Regarding "Antireflux Surgery Versus Antireflux Medication and Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus"

Gastroenterology. 2024 May;166(5):943. doi: 10.1053/j.gastro.2023.09.025. Epub 2023 Sep 22.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adenocarcinoma* / surgery
  • Barrett Esophagus* / drug therapy
  • Barrett Esophagus* / surgery
  • Esophageal Neoplasms* / surgery
  • Fundoplication / adverse effects
  • Gastroesophageal Reflux* / complications
  • Gastroesophageal Reflux* / diagnosis
  • Gastroesophageal Reflux* / drug therapy
  • Humans
  • Proton Pump Inhibitors* / adverse effects
  • Proton Pump Inhibitors* / therapeutic use
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome

Substances

  • Proton Pump Inhibitors

Supplementary concepts

  • Adenocarcinoma Of Esophagus